Matinas biopharma announces accomplished biotechnology executive and drug developer kathryn penkus corzo as nominee to the board of directors

– ms. corzo brings a 25+ year successful track record in biopharma, excelling in oncology drug development with takeda, sanofi genzyme, and eli lilly –

MTNB Ratings Summary

MTNB Quant Ranking